U.S. Nebulizer (Jet, Mesh, Ultrasonic) Market Analysis Report 2024-2030: Home Healthcare Trends, Unhealthy Lifestyles and High Obesity Rates Contribute to Surge in Adoption


Dublin, Oct. 04, 2024 (GLOBE NEWSWIRE) -- The "U.S. Nebulizer Market Size, Share & Trends Analysis Report By Type (Jet, Mesh, Ultrasonic), By Application (COPD, Asthma), By End-use (Hospitals & Clinics, Emergency Centers), And Segment Forecasts, 2024 - 2030" report has been added to ResearchAndMarkets.com's offering.

U.S. Nebulizer Market Growth & Trends

The U.S. nebulizer market size is anticipated to reach USD 412.6 million by 2030, expanding at a 5.4% CAGR

Rising incidence of chronic respiratory diseases in U.S., increasing demand for home healthcare devices, and growing geriatric population are among the key factors driving market growth.



Rising incidence of chronic respiratory diseases is a crucial driver for market growth. Factors such as overconsumption of tobacco and alcohol, unhealthy diet, lack of physical activity, and alarming rates of obesity are also likely to lead to an increase in incidence of respiratory disorders in U.S., contributing to the growth of the nebulizer market over the forecast period.

Home healthcare devices have been gaining popularity and market share in recent years. Growing geriatric population in U.S., high incidence of target diseases, and rising need to curb healthcare expenditure are expected to be some of the high-impact rendering drivers for home healthcare devices. Home healthcare is a cost-effective alternative to expensive hospital stays.

Easy availability of compact nebulizers ideal for home use and technological innovations in nebulizers to reduce noise and improve functionality are increasing their adoption in home healthcare. Moreover, third-party payers, such as insurance companies, favor such devices as they aim to reduce costs while providing quality healthcare services. Such factors are also expected to contribute to market growth.

U.S. Nebulizer Market Report Highlights

  • Mesh is expected to register the fastest CAGR of 5.8% over the forecast period owing to its advanced technology that provides fast and highly effective drug delivery when compared to that of a usual nebulizer.
  • The asthma segment dominated the market in 2023 and accounted for a market share of 40.0% driven by the high prevalence of asthma, which requires regular and effective administration of drugs for disease management.
  • The hospitals and clinics segment dominated the market in 2023. The hospitals and clinics provide a controlled environment with physicians trained to administer nebulized drugs, especially for critical cases or patients who require intensive care.

Companies Featured

  • OMRON Healthcare, Inc.
  • GE Healthcare
  • Koninklijke Philips N.V.
  • Allied Healthcare
  • Vectura Group Plc.
  • PARI Respiratory Equipment, Inc.
  • Aerogen
  • DeVilbiss Healthcare LLC
  • Briggs Healthcare
  • Beurer GmBH

Key Attributes:

Report AttributeDetails
No. of Pages70
Forecast Period2023 - 2030
Estimated Market Value (USD) in 2023$287.2 Million
Forecasted Market Value (USD) by 2030$412.6 Million
Compound Annual Growth Rate5.4%
Regions CoveredUnited States



Key Topics Covered:

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.4. Research Scope and Assumptions

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. U.S. Nebulizer Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. U.S. Nebulizer Market Analysis Tools
3.4.1. Porter's Analysis
3.4.2. PESTEL Analysis

Chapter 4. U.S. Nebulizer Market: Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. U.S. Nebulizer Market: Type Movement Analysis, 2023 & 2030 (USD Million)
4.3. Jet
4.4. Mesh
4.5. Ultrasonic

Chapter 5. U.S. Nebulizer Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. U.S. Nebulizer Market: Application Movement Analysis, 2023 & 2030 (USD Million)
5.3. COPD
5.4. Asthma
5.5. Others

Chapter 6. U.S. Nebulizer Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. U.S. Nebulizer Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
6.3. Hospitals and Clinics
6.4. Emergency Centers
6.5. Others

Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis by Key Market Participants
7.2. Company Categorization
7.3. Company Heat Map Analysis
7.4. Company Profiles
7.4.1. Participant's Overview
7.4.2. Financial Performance
7.4.3. Product Benchmarking
7.4.4. Recent Developments/ Strategic Initiatives

For more information about this report visit https://www.researchandmarkets.com/r/j9s5uk

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

 
U.S. Nebulizer Market

Contact Data